
Updated for 2026
Both gastric sleeve and gastric bypass are both known to reduce obesity-related comorbidities, including type 2 diabetes. But gastric bypass does it quicker. Here’s why.
One of the great advantages of the gastric bypass is its effectiveness in resolving type 2 diabetes. We know that obesity and excess weight in general increase the risk of diabetes. Logically, therefore, we believed that significant excess weight loss offered by the gastric bypass would resolve it quickly.
But there was a nagging question.
We noticed that the improvement, even remission, of type two diabetes happened more quickly and at a higher rate than restrictive procedures like a sleeve gastrectomy – within days or just a couple of weeks of the procedure. This was puzzling because patients would not yet have lost a significant amount of weight. So what mechanism makes gastric bypass so effective that it can improve diabetes before the patient loses a significant amount of weight?
The truth is, we still don’t know the exact reason, but we have some strong theories. These theories came about as we learned more about weight loss surgery and its effect on metabolism. The purpose of these surgeries is to improve or resolve the many diseases associated with morbid obesity, alongside weight loss.
Gastric bypass is one of the best weight loss surgeries for getting diabetes under control, and surgeries like SADI and duodenal switch are great procedures for people with a BMI of 55 or greater and those who have a difficult time controlling their blood sugar.
What the Research Says
- Weight loss does make a difference. Research has shown that as we lose weight, we regain some insulin sensitivity.¹ This, however, is the case for both restrictive (gastric sleeve and gastric band) and combination restrictive-malabsorptive procedures, but it doesn’t explain the rapidity of the improvement compared to bypass.
- Somewhat more specific to the gastric bypass is the theory of reduced lipotoxicity. Research has shown that insulin sensitivity increased after the gastric bypass more rapidly than weight loss alone.² An intestinal surgery somehow reduces the toxicity of fat cells in our bodies.
- The strongest evidence is for what researchers call the “hindgut” hypothesis. After gastric bypass, nutrients reach the lower intestine more quickly, triggering the release of gut hormones such as GLP-1 and PYY that help the body release insulin and control blood sugar, leading to rapid improvements in type 2 diabetes after surgery.³
As a side note, the gastric bypass is also exceptionally effective for patients suffering from gastroesophageal reflux disease or GERD.
Does That Mean the Gastric Bypass Patients No Longer Have to Worry About Diabetes?
Diabetes is a chronic disease, and gastric bypass simply puts diabetes into remission, but there’s always the chance that the disease can return. Gastric bypass patients should be mindful of their lifestyle and maintain the dietary and exercise changes that brought on successful weight loss in the first place.
With weight loss, many times blood sugar can be controlled, and if you maintain your weight loss, then this will be a long-term effect. But we cannot say your diabetes has been “cured.” If the weight comes back, so can diabetes.
Choosing a bariatric procedure starts with a little research and a conversation with a bariatric surgeon. You’ll discuss your health, weight history, eating patterns, medications, previous attempts at weight loss, and what you hope surgery will accomplish so your specialist can then explain which procedures fit your situation, how each one works, what changes you can expect afterward, and the potential risks and benefits. Together, you can weigh those factors against your preferences, lifestyle, and long-term goals to decide which procedure makes the most sense for you. No two patients are the same – what was appropriate for a friend or family member may not necessarily be right for you.
If you’re ready to make the decision, start by watching our online seminar. You can also contact us for a consultation. The team at SAMPA is happy to answer any questions you may have.
References:
- Clamp, L. D., Hume, D. J., Lambert, E. V., & Kroff, J. (2017). Enhanced insulin sensitivity in successful, long-term weight loss maintainers compared with matched controls with no weight loss history. Nutrition & diabetes, 7(6), e282. https://doi.org/10.1038/nutd.2017.31.
- He, B., Liu, L., Yu, C., Wang, Y., & Han, P. (2014). Roux-en-Y gastric bypass reduces lipid overaccumulation in liver by upregulating hepatic autophagy in obese diabetic rats. Obesity Surgery, 25, 109–118. https://doi.org/10.1007/s11695-014-1342-7.
- Yin, M., Wang, Y., Han, M., Liang, R., Li, S., Wang, G., & Gang, X. (2023). Mechanisms of bariatric surgery for weight loss and diabetes remission. Journal of diabetes, 15(9), 736–752. https://doi.org/10.1111/1753-0407.13443.

